Work

Vemurafenib Has Potent Antitumor Activity in Patients with Relapsed/Refractory BRAF Mutant Hairy Cell Leukemia

Year: 2014

Type: article

Source: Blood

DOI: 10.1182/blood.v124.21.24.24

Authors: Jae H Park, Stephen S. Chung, Young Rock Chung, Helen Won, Eunhee Kim, Alan Saven, Martha Wadleigh, Richard M. Stone, Jacqueline C. Barrientos, Kanti R. Rai, Michael R. Grever, Jessica K. Altman, Mario E Lacouture, Neal Rosen, Michael Berger, Ross L Levine, Omar Abdel-Wahab, Martin S. Tallman

Institutions: Memorial Sloan Kettering Cancer Center, Scripps Health, Dana-Farber Cancer Institute, Northwell Health, Hofstra University, The Ohio State University, Northwestern University

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2989259260

FWCI: 0.753

Cites:

Cited by: 5

Related to: 10